ICER report reviews possible drug pricing approaches for coronavirus crisis
The US Institute for Clinical and Economic Review (ICER) has released a report considering possible approaches to the challenge of … read more »
Branded medicines statutory scheme consultation concluded
The Department of Health and Social Care (DHSC) has published the results of the consultation changes to the Statutory Scheme … read more »
Price moratorium remains in Germany
Since 2009, a price moratorium has been in place in Germany preventing the increase of some medicine prices. The annual … read more »
Japan announces products to be repriced
The Ministry of Health, Labour and Welfare (MHLW) has revealed the 17 drugs for which it plans to review prices … read more »
Government study suggests Finnish medicine pricing system results in higher prices
A study published by The Ministry of Social Affairs and Health shows if Finland had adopted systems similar to those … read more »
ABPI: Voluntary Scheme expected to boost NHS Scotland by £70 million
ABPI Scotland has reported the Voluntary Scheme is returning £1 million per week to NHS Scotland, and might reach £70 … read more »
Consultation on changes to Statutory Scheme
The UK Government has opened a consultation into the Statutory Scheme including adjustments to the payment percentages to be used … read more »
DHSC announces Voluntary Scheme rate of 5.9% for 2020
The Department of Health and Social Care (DHSC) has announced the percentage repayment that will be required on NHS drug … read more »
Proposal for a new model of pricing medicines in the EU
The Association Internationale de la Mutualité (AIM) has launched a new model for pricing medicines which they believe is fairer … read more »
Price cuts from manufacturers ensures reimbursement in China
Reports show that global manufacturers of medicines have been prepared to cut drugs prices by 61%, on average, in order … read more »
